UnitedHealth Group Incorporated (UNH)
NYSE: UNH · Real-Time Price · USD
404.19
+2.76 (0.69%)
Oct 19, 2026, 9:45 AM EDT - Market open

UnitedHealth Group Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Premiums & Annuity Revenue
87,07886,95687,56188,81188,97987,90586,53476,48377,44276,89777,98873,22872,33972,47472,78664,70064,49163,89664,07057,547
Total Interest & Dividend Income
1,0771,2231,1311,0441,1321,1081,0331,5511,6439971,0111,1799971,115798855513295367813
Non-Insurance Activities Revenue
14,29313,83513,25013,48413,29613,56413,03613,47512,63112,21111,90911,31110,35410,65110,2679,3989,1909,4969,3408,961
Other Revenue
10,24610,0189,77910,2739,7549,0398,9729,2989,1048,7508,8888,7098,6718,6638,0807,8346,7006,6456,3726,422
112,694112,032111,721113,612113,161111,616109,575100,807100,82098,85599,79694,42792,36192,90391,93182,78780,89480,33280,14973,743
Revenue Growth (YoY)
-0.41%0.37%1.96%12.70%12.24%12.91%9.80%6.76%9.16%6.41%8.55%14.06%14.17%15.65%14.70%12.26%11.83%12.63%14.18%12.64%
Policy Benefits
76,98275,35873,48981,41879,95878,58573,41167,03565,95765,45865,73562,23159,55060,26859,84553,59152,63552,09352,52348,159
Depreciation & Amortization
1,0731,0401,0291,1171,0991,0841,0611,0411,0411,0209979741,0071,021970982828802788771
Selling, General & Administrative
14,36914,26815,39015,59715,22313,77813,59412,49413,28013,16214,07713,33913,85513,80913,62513,00911,66311,70911,40111,272
Non-Insurance Activities Expense
13,70713,37512,82312,68012,56613,01912,39012,46411,83411,34011,05610,1949,4239,7489,4058,3148,3068,5968,4878,000
Total Operating Expenses
106,131104,041102,731110,812108,846106,466100,45693,03492,11290,98091,86586,73883,83584,84683,84575,89673,43273,20073,19968,202
Operating Income
6,5637,9918,9902,8004,3155,1509,1197,7738,7087,8757,9317,6898,5268,0578,0866,8917,4627,1326,9505,541
Interest Expense
-963-962-955-974-1,003-1,027-998-1,003-1,074-985-844-830-834-828-754-676-516-467-433-431
EBT Excluding Unusual Items
5,6007,0298,0351,8263,3124,1238,1216,7707,6346,8907,0876,8597,6927,2297,3326,2156,9466,6656,5175,110
Merger & Restructuring Charges
----2,420----------------
Gain (Loss) on Sale of Assets
-76-61-72-126-83-41-1521-20-1,225-7,086---------
Pretax Income
5,5246,9687,963-7203,2294,0828,1066,7917,6145,66516,8597,6927,2297,3326,2156,9466,6656,5175,110
Income Tax Expense
1,2241,2981,482-9386865101,6321,0071,3561,2441,2221,1841,6541,5721,5581,3071,5621,4661,369919
Earnings From Continuing Ops.
4,3005,6706,4812182,5433,5726,4745,7846,2584,421-1,2215,6756,0385,6575,7744,9085,3845,1995,1484,191
Minority Interest in Earnings
-190-186-201-208-195-166-182-241-203-205-188-220-197-183-163-147-122-129-121-120
Net Income
4,1105,4846,280102,3483,4066,2925,5436,0554,216-1,4095,4555,8415,4745,6114,7615,2625,0705,0274,071
Net Income to Common
4,1105,4846,280102,3483,4066,2925,5436,0554,216-1,4095,4555,8415,4745,6114,7615,2625,0705,0274,071
Net Income Growth (YoY)
75.04%61.01%-0.19%-99.82%-61.22%-19.21%-1.61%3.66%-22.98%-14.58%11.00%7.97%11.62%16.95%28.78%18.85%3.39%84.04%
Shares Outstanding (Basic)
902902908910906907912927923921922935926930933947935937941955
Shares Outstanding (Diluted)
902906910910908910918927930928922935936940943947948950954955
Shares Change (YoY)
-0.66%-0.44%-0.87%-1.83%-2.37%-1.94%-0.43%-0.86%-0.64%-1.28%-2.23%-1.27%-1.27%-1.05%-1.15%-0.84%-0.73%-0.63%-0.31%-0.62%
EPS (Basic)
4.566.086.920.012.593.766.905.986.564.58-1.535.836.315.896.015.035.635.415.344.26
EPS (Diluted)
4.566.046.900.012.593.746.855.986.514.54-1.535.836.245.825.955.035.555.345.274.26
EPS Growth (YoY)
75.93%61.50%0.73%-99.91%-60.21%-17.62%-2.56%4.33%-21.99%-15.97%12.43%8.99%12.90%17.94%29.67%19.73%3.74%85.34%

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
4,26410,2538,1491605,0556,3024,5581,45712,9545,893401-6,1526,06410,20315,567-5,39917,8256,2144,7642,523
Free Cash Flow Per Share
4.7311.328.960.185.576.924.961.5713.936.350.43-6.586.4810.8516.51-5.7018.806.544.992.64
Dividend Per Share
-2.3202.2102.2102.2102.2102.1002.1002.1002.1001.8801.8801.8801.8801.6501.6501.6501.6501.4501.450
Dividend Growth (YoY)
-4.98%5.24%5.24%5.24%5.24%11.70%11.70%11.70%11.70%13.94%13.94%13.94%13.94%13.79%13.79%13.79%13.79%16.00%16.00%
Operating Margin
5.82%7.13%8.05%2.46%3.81%4.61%8.32%7.71%8.64%7.97%7.95%8.14%9.23%8.67%8.80%8.32%9.22%8.88%8.67%7.51%
Profit Margin
3.65%4.90%5.62%0.01%2.08%3.05%5.74%5.50%6.01%4.26%-1.41%5.78%6.32%5.89%6.10%5.75%6.50%6.31%6.27%5.52%
Free Cash Flow Margin
3.78%9.15%7.29%0.14%4.47%5.65%4.16%1.44%12.85%5.96%0.40%-6.51%6.57%10.98%16.93%-6.52%22.04%7.74%5.94%3.42%
EBITDA
7,6369,03110,0193,9175,4146,23410,1808,8149,7498,8958,9288,6639,5339,0789,0567,8738,2907,9347,7386,312
EBITDA Margin
6.78%8.06%8.97%3.45%4.78%5.58%9.29%8.74%9.67%9.00%8.95%9.17%10.32%9.77%9.85%9.51%10.25%9.88%9.65%8.56%
D&A For EBITDA
1,0731,0401,0291,1171,0991,0841,0611,0411,0411,0209979741,0071,021970982828802788771
EBIT
6,5637,9918,9902,8004,3155,1509,1197,7738,7087,8757,9317,6898,5268,0578,0866,8917,4627,1326,9505,541
EBIT Margin
5.82%7.13%8.05%2.46%3.81%4.61%8.32%7.71%8.64%7.97%7.95%8.14%9.23%8.67%8.80%8.32%9.22%8.88%8.67%7.51%
Effective Tax Rate
22.16%18.63%18.61%-21.25%12.49%20.13%14.83%17.81%21.96%122200.00%17.26%21.50%21.75%21.25%21.03%22.49%22.00%21.01%17.98%
Revenue as Reported
112,694112,032111,721113,215113,161111,616109,575100,807100,82098,85599,79694,42792,36192,90391,93182,78780,89480,33280,14973,743
SEC Filings: 10-K · 10-Q